Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS) and the Department of Commerce (DOC) ...

Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.

Under CEO Richard Francis’ “Pivot to Growth” strategy, Teva Pharmaceutical Industries has undergone a significant ...

Ro is bringing Serena Williams to the Super Bowl. Months after partnering with Williams, Ro has secured airtime at Super Bowl LX to showcase how the 23-time Grand Slam tennis champion’s life changed ...

With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, ...

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...

"Detect the SOS is a multi-stakeholder movement that brings together trusted voices, advocates, healthcare professionals and ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

In an agreement that seemingly bodes well for the flow of pharmaceuticals between the two regions, the EU and India on Monday agreed to a sweeping free trade agreement that the European bloc has ...

After posting 16.2% revenue growth in the last financial year, Servier President Olivier Laureau said the company has moved ...

But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...